Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Cánceres del Pulmón / Cáncer del Pulmón de Célula No Pequeña / Recursos de NCI
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - October 2001
Postoperative adjuvant therapy for stage IB non-small-cell lung cancer. Small cell lung cancer I--III A: cytoreductive chemotherapy followed by resection with continuation of chemotherapy. Use of neuroendocrine markers, p53, and HER2 to predict... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - September 2001
Table of ContentsA three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer.A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: toxicity of... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - October 2001
Prognostic significance of pleural lavage cytology after resection for non-small cell lung cancer. Is lung cancer surgery justified in patients with direct mediastinal invasion? Surgical treatment of lung cancer invading chest wall: a... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - September 2001
Table of ContentsQuality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.Do patients with nonmetastatic non-small... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - April 2002
Chemotherapy and quality of life in advanced NSCLC. Neoadjuvant chemotherapy in non small cell lung cancer-the UK experience. The role of photodynamic therapy in the management of stage I/II NSCLC. Chemotherapy for early stage non-small cell... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - August 2002
OSI Pharmaceuticals, Genentech and Roche announce data from clinical studies of Tarceva. The early rad catches the tumor? Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - February 2002
Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study. Neoadjuvant strategies for non-small cell lung cancer. Principles of induction chemotherapy for non-small cell lung cancer.... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - January 2002
Nonsurgical management of non-small-cell lung cancer. Advances in chemotherapy for small cell lung cancer: single-agent activity of newer agents. The role of cisplatin in the treatment of small-cell lung cancer? Superiority of high-dose... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - July 2002
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. Chemotherapy for non-small-cell lung cancer. Chemotherapy for non-small-cell lung cancer. Chemotherapy in advanced... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - June 2002
First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a Preoperative chemotherapy in non-small-cell lung cancer: nothing new in N2 disease. A... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - March 2002
Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer. A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - May 2002
Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - October 2002
Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic Where to go with new expensive treatments in NSCLC. Dose-intense phase II study of weekly cisplatin... |
|
|
NCI CANCERLIT® Search: Chemotherapy for Non-small Cell Lung Cancer - September 2002
The role of high-dose chemotherapy in the treatment of non-small cell lung cancer. Targeting epidermal growth factor receptor in lung cancer. Angiogenesis inhibitors in lung cancer. In regard to Rosenzweiz et al. IJROBP 2001;50:681-685. ... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - April 2002
Neoadjuvant chemotherapy in non small cell lung cancer-the UK experience. Radiation therapy of stage I and II non-small cell lung cancer (NSCLC). Multimodality therapy for non-small cell lung cancer (NSCLC): ongoing Italian experiences in... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - August 2002
Stage III non-small cell lung cancer and metachronous brain metastases. The early rad catches the tumor? Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - February 2002
[Clinical study of prophylactic cranial irradiation for small-cell lung cancer] Surgery for non-small cell lung cancer. Surgery for non-small cell lung cancer--new trends. Surgical treatment of stage III non-small cell lung cancer. Neoadjuvant... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - January 2002
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. Subclassification of N2 non-small-cell lung cancer. Nonsurgical management of non-small-cell lung cancer. Meta-analysis of... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - July 2002
Morbidity after induction therapy and surgery in non small cell lung cancer (NSCLC). Focus on pulmonary function. [Surgical treatment for metastatic renal cell tumors of the lung] Disparities in surgical resection of early-stage non-small... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - June 2002
Meeting patients' post-discharge needs after lung cancer surgery. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung Adequate lymph node staging is... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - March 2002
A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Role of fiberscopic transbronchial needle... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - May 2002
Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 Effectiveness of positron emission tomography in the preoperative assessment of patients with... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - October 2002
Characteristics and prognosis of resected T3 non-small cell lung cancer. Management of superior sulcus tumors: experience with 139 cases treated by surgical resection. Sleeve lobectomy for bronchogenic cancers: factors affecting survival. ... |
|
|
NCI CANCERLIT® Search: Radiation, Surgery for Non-small Cell Lung Cancer - September 2002
Differentiated thyroid cancer in children and adolescents. Three-dimensional conformal radiotherapy for lung cancer: promises and pitfalls. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell... |
|
|
NCI/PDQ® Health professionals: Non-Small Cell Lung Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Non-Small Cell Lung Cancer (NSCLC)Incidence and MortalityAnatomyPathogenesisPathologyRisk FactorsPreventionScreeningClinical FeaturesDiagnosisMolecular FeaturesPrognostic FactorsRelated SummariesCellular... |
|
|
NCI/PDQ® Pacientes: Cáncer de pulmón de células no pequeías: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer de pulmón de células no pequeíasEstadios del cáncer de pulmón de células no pequeíasCáncer de pulmón de células no pequeías... |
|
|
NCI/PDQ® Patients: Non-Small Cell Lung Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Non-Small Cell Lung CancerStages of Non-Small Cell Lung CancerRecurrent Non-Small Cell Lung CancerTreatment Option OverviewTreatment Options by StageOccult Non-Small Cell Lung CancerStage 0 (Carcinoma in... |
|
|
NCI/PDQ® Profesionales De Salud: Cáncer de pulmón de células no pequeías: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer de pulmón de células no pequeías (CPCNP)Incidencia y mortalidadAnatomíaPatogeniaPatologíaFactores de riesgoPrevenciónPruebas de... |
Marianna talks about what makes a great oncology nurse and how the experience of caring for people with cancer is a rewarding career. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

